These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The clinical pharmacokinetics of the new antiepileptic drugs. Perucca E Epilepsia; 1999; 40 Suppl 9():S7-13. PubMed ID: 10612356 [TBL] [Abstract][Full Text] [Related]
25. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Marson AG; Kadir ZA; Hutton JL; Chadwick DW Epilepsia; 1997 Aug; 38(8):859-80. PubMed ID: 9579887 [TBL] [Abstract][Full Text] [Related]
26. The new antiepileptic drugs. Appleton RE Arch Dis Child; 1996 Sep; 75(3):256-62. PubMed ID: 8976672 [No Abstract] [Full Text] [Related]
27. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387 [TBL] [Abstract][Full Text] [Related]
28. Felbamate in the treatment of partial-onset seizures. Bourgeois BF Epilepsia; 1994; 35 Suppl 5():S58-61. PubMed ID: 8039474 [TBL] [Abstract][Full Text] [Related]
30. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials. Leiderman DB Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475 [TBL] [Abstract][Full Text] [Related]
31. Felbamate, gabapentin and topiramate as adjuvant antiepileptic drugs in experimental models of epilepsy. Czuczwar SJ; Przesmycki K Pol J Pharmacol; 2001; 53(1):65-8. PubMed ID: 11785915 [TBL] [Abstract][Full Text] [Related]
33. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group. Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624 [TBL] [Abstract][Full Text] [Related]
34. Aggravation of focal epileptic seizures by antiepileptic drugs. Elger CE; Bauer J; Scherrmann J; Widman G Epilepsia; 1998; 39 Suppl 3():S15-8. PubMed ID: 9593231 [TBL] [Abstract][Full Text] [Related]
35. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience. Ben-Menachem E Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ; Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821 [TBL] [Abstract][Full Text] [Related]
37. Role of new and established antiepileptic drugs. Leppik IE Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436 [No Abstract] [Full Text] [Related]
38. Felbamate: successful development of a new compound for the treatment of epilepsy. Schmidt D Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376 [TBL] [Abstract][Full Text] [Related]
39. Expanding antiepileptic drug options: clinical efficacy of new therapeutic agents. Ben-Menachem E Epilepsia; 1996; 37 Suppl 2():S4-S7. PubMed ID: 8641244 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience. Faught E Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]